NeuroEM Therapeutics Closes Preliminary Rounds in $5 Million Fairness Increase to Commercialize Drug-free Alzheimer’s Therapy

NeuroEM Therapeutics, an award-winning clinical-stage biotechnology analysis firm pioneering the usage of radio frequencies to reverse Alzheimer’s illness, has closed preliminary rounds totaling $1.33 million of a $5 million fairness increase with BlueLake.vc.

The Sequence A spherical helps continued progress towards commercialization of NeuroEM’s Transcranial Electromagnetic Therapy (TEMT-RF) to stop and deal with cognitive decline attributable to getting old or Alzheimer’s and different neurodegenerative illnesses.

“BlueLake’s help demonstrates the significance of sustaining our momentum within the execution of key scientific, regulatory, and industrial milestones on our journey towards a secure, efficient, drug-free therapy for Alzheimer’s dementia and different neurodegenerative illnesses,” says Chuck Papageorgiou, CEO of NeuroEM Therapeutics. “It fuels the tireless efforts of our researchers, clinicians, engineers, and the complete NeuroEM workforce to revive the hope and dignity Alzheimer’s illness has already stolen from hundreds of thousands and to in the future forestall hundreds of thousands extra from dealing with this devastating prognosis.”

The fairness spherical is led by BlueLake Companion Jamie Rutledge, who additionally joins the NeuroEM Board of Administrators. Rutledge focuses on early-stage investments in breakthrough applied sciences at BlueLake and is a seasoned expertise investor and govt with deep experience in strategic funding and innovation throughout the medical expertise and shopper electronics sectors.

He brings greater than 25 years of expertise to NeuroEM, together with senior management roles at Dyson and Lenovo. He beforehand led Lenovo’s Strategic Enterprise Capital and Open Innovation initiatives and directed expertise scouting and strategic investments at Dyson.

“NeuroEM’s pioneering, non-invasive strategy to treating and stopping Alzheimer’s represents precisely the form of patented, deep tech innovation we champion at BlueLake—transformative, defensible, and grounded in scientific rigor. This strategy to drug-free therapy and prevention of Alzheimer’s holds large promise in tackling a illness that has eluded efficient options for many years,” mentioned Rutledge. “We’re proud to help the development of this groundbreaking expertise, and I’m personally honored to assist information NeuroEM because it brings progressive, non-invasive therapies to the forefront of neurodegenerative care.”

Provides Papageorgiou, “Jamie’s background in radio frequency techniques, embedded gadgets, and product improvement aligns intently with our core expertise, and his strategic perception might be a worthwhile asset as NeuroEM strikes towards commercialization and broader market engagement.”

NeuroEM Therapeutics, a member of StartUp Well being’s Alzheimer’s Moonshot Group, is dedicated to creating, clinically testing, and advertising and marketing its multi-patented TEMT-RF applied sciences that concentrate on and cut back cognitive decline and restore immune stability within the mind and blood whereas boosting vitality manufacturing in mind cells—vital parts for optimum cognitive perform. Early research have demonstrated that, as an Alzheimer’s therapy, TEMT-RF is secure, enhances cognitive perform, and should probably modify the illness itself.

The corporate’s first industrial product, a light-weight cap designed for at-home use, is at the moment beneath improvement and has proven extraordinary promise in preclinical and scientific research. Worn for an hour twice day by day, the machine makes use of quick pulses of vitality in particular ultra-high frequencies to ship a transcranial electromagnetic therapy that improves key bodily components within the mind on the root of cognitive decline.

BlueLake Ventures invests in utilized deep tech for the way forward for work and well being, expertise outlined by important boundaries to entry, corresponding to sturdy patent safety or specialised area experience. Its workforce consists of skilled operators who’ve constructed and scaled startup firms, held govt positions in multi-national firms, constructed partnerships between startups and firms, and deployed strategic enterprise capital in technology-driven companies. By leveraging its experience, sources, and networks, BlueLake goals to speed up the expansion of deep tech improvements that empower each companies and customers.